Dr. Kailash Mosalpuria, MD, MPH
- Medicare services, 2024
- 240,004
- Medicare patients, 2024
- 865
- Part D claims, 2024
- 1,496
- Clinical trials
- 1
- Hospital affiliations
- 6
- Practice address
- 4004 Pioneer Woods Dr, Lincoln, NE 68506
- Practice phone
- Call (402) 484-4900
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Nebraska Hematology-Oncology
Lincoln, Nebraska
Find Dr. Mosalpuria's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Kailash Mosalpuria is a hematologist and oncologist in Lincoln, Nebraska
Dr. Mosalpuria practices at Nebraska Hematology-Oncology in Lincoln, Nebraska.
Dr. Mosalpuria's NPI, 1669636643, was assigned on July 18, 2008. Dr. Mosalpuria holds Nebraska license 27604.
- NPI
- 1669636643NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2860623881
- NPI enumeration date
- July 18, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (402) 484-4900
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 47
- Medical school graduation
- 2005
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Kailash Mosalpuria practices at Nebraska Hematology-Oncology in Lincoln, Nebraska
Dr. Mosalpuria's primary practice is Nebraska Hematology-Oncology, at 4004 Pioneer Woods Dr, Lincoln, NE 68506 in Lancaster County. The practice phone is (402) 484-4900.
- Nebraska Hematology-Oncology4004 Pioneer Woods Dr, Lincoln, NE 68506 · Lancaster CountyPhone(402) 484-4900
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Kailash Mosalpuria is affiliated with 8 sites of care and 2 medical groups
Dr. Mosalpuria's primary practice is Nebraska Hematology-Oncology in Lincoln, Nebraska. Dr. Mosalpuria is also affiliated with Bryan Medical Center. The medical group on file is Nebraska Hematology-Oncology. Dmand AI also links Dr. Mosalpuria to 5 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Kailash Mosalpuria's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mosalpuria practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Nebraska Hematology-Oncology | Available with a free account |
| +7 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Kailash Mosalpuria is one of 80 hematologists and oncologists in Nebraska
Hematology and oncology is Dr. Mosalpuria's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mosalpuria is licensed in Nebraska.
Specialties and state licenses
- Hematology and oncology, NebraskaPrimary
Hematologists and oncologists near Dr. Mosalpuria
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Kailash Mosalpuria billed Medicare for 240,004 services in 2024
CMS data shows 240,004 Medicare services from Dr. Mosalpuria across 88 procedure codes in 2024, for 865 Medicare patients. Medicare paid $3,917,238 for them.
Dr. Mosalpuria's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 204,1172024: 221,2218%
- Lab and pathology
- 2023: 7,0522024: 8,03414%
- Tests and treatments
- 2023: 3,3682024: 4,13323%
- Other services
- 2023: 5,5932024: 3,49138%
- Office and hospital visits
- 2023: 1,3902024: 1,56413%
- Surgery
- 2023: 1,3992024: 1,56112%
Where Dr. Mosalpuria's Medicare services took place, 2024
- In an office239,830100%
- In a facility1740%
Dr. Mosalpuria compared with the Nebraska median for hematologists and oncologists, 2024
- Dr. Mosalpuria
- Nebraska median
- Medicare services
- 240,004vs 1,322181.5 times
- Medicare patients
- 865vs 4082.1 times
- Part D claims
- 1,289vs 5492.3 times
Medians across 79 hematologists and oncologists in Nebraska with Dmand AI profiles that report each measure.
Dr. Mosalpuria's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Mosalpuria?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mosalpuria and other hematologists and oncologists in Nebraska.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Kailash Mosalpuria treated 865 Medicare patients in 2024, average age 75
CMS counts 865 Medicare patients who saw Dr. Mosalpuria in 2024. The largest group is 65 to 74, with 390 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Mosalpuria's median patient age at 70, with 54% women.
Dr. Mosalpuria's Medicare patients by age, 2024
Dr. Mosalpuria's Medicare patients by sex, 2024
- Women45553%
- Men41047%
Chronic conditions among Dr. Mosalpuria's Medicare patients, 2024
- High blood pressure75%
- High cholesterol72%
- Cancer49%
- Arthritis48%
- Chronic kidney disease35%
- Diabetes31%
- Ischemic heart disease29%
- Heart failure28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Mosalpuria's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women54%
- Men45%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Kailash Mosalpuria wrote 1,496 Medicare Part D claims in 2024
In 2024, Dr. Mosalpuria wrote 1,496 Medicare Part D claims for 245 patients. 68% of them were for generic drugs. CMS names the drug for 1,289 of them, across 33 drugs with 11 or more claims each, at $6,316,997 in total drug cost. In 2023, CMS named 929 claims across 30 drugs.
Dr. Mosalpuria's Part D claims by kind of drug, 2024
- Generic1,010 claims68%
- Brand-name486 claims32%
Dr. Mosalpuria's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Mosalpuria's Part D claims, 2024
- Opioids1%17 of 1,496 claims
- Antibiotics7%108 of 1,496 claims
- Antipsychotics, patients 65 and over2%27 of 1,496 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 9292024: 1,28939%
Drugs named by CMS: 33 in 2024, 30 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Kailash Mosalpuria offers telehealth to Medicare patients
Dr. Mosalpuria accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mosalpuria as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)
Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Kailash Mosalpuria has worked on 1 clinical trial
Dmand AI links Dr. Mosalpuria to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell and Leukemia, B-Cell. Open Payments lists research payments to Dr. Mosalpuria that name 4 trials.
Conditions in Dr. Mosalpuria's trials
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, B-Cell
Investigators on the most trials with Dr. Mosalpuria
- Ghassan Al-Jazayrly, MD1 shared trial
- Omar Alkharabsheh, MD1 shared trial
- Ayed O. Ayed, MD1 shared trial
Recent clinical trials with Dr. Mosalpuria
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Kailash Mosalpuria received $20,386 in industry payments from 2016 to 2025
CMS Open Payments shows 154 general payments to Dr. Mosalpuria from 43 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Geron Corporation paid the most, $3,582. It also lists 6 research payments totaling $1,123 from 2023 to 2025, naming 4 clinical trials.
General payments to Dr. Mosalpuria by program year, 2016 to 2025
General payments to Dr. Mosalpuria by kind, 2016 to 2025
- Consulting fees$11,77058%
- Travel and lodging$3,25816%
- Speaker and faculty fees$2,54312%
- Food and beverage$2,25011%
- Education$5673%
Companies that paid Dr. Mosalpuria the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Kailash Mosalpuria's profile data
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Kailash Mosalpuria
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Kailash Mosalpuria's NPI number?
Dr. Kailash Mosalpuria's NPI number is 1669636643. It was assigned on July 18, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Kailash Mosalpuria?
Dr. Kailash Mosalpuria is a hematologist and oncologist in Lincoln, Nebraska. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Kailash Mosalpuria practice?
Dr. Mosalpuria practices at 4004 Pioneer Woods Dr, Lincoln, NE 68506. Dr. Mosalpuria's primary practice is Nebraska Hematology-Oncology in Lincoln, Nebraska. Dmand AI also links Dr. Mosalpuria to 5 hospitals, 1 group practice or clinic and 1 medical group.
What is Dr. Kailash Mosalpuria's office phone number?
The practice phone on file for Dr. Mosalpuria is (402) 484-4900.
What is Dr. Kailash Mosalpuria's medical license number?
Dr. Mosalpuria holds Nebraska license 27604.
Which hospitals is Dr. Kailash Mosalpuria affiliated with?
Dr. Mosalpuria is affiliated with Bryan Medical Center. Dmand AI links Dr. Mosalpuria to 5 more hospitals.
What medical group is Dr. Kailash Mosalpuria part of?
Dr. Mosalpuria is linked to Nebraska Hematology-Oncology. Dmand AI links Dr. Mosalpuria to 1 more medical group.
Does Dr. Kailash Mosalpuria accept Medicare?
Yes. CMS data shows Dr. Mosalpuria billed Medicare for 240,004 services in 2024, and Dr. Mosalpuria accepts Medicare assignment.
Does Dr. Kailash Mosalpuria offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Mosalpuria as offering telehealth services.
How many Medicare patients does Dr. Kailash Mosalpuria see?
CMS counts 865 Medicare patients who saw Dr. Mosalpuria in 2024, with an average age of 75.
Show 5 more questionsShow fewer questions
What services does Dr. Kailash Mosalpuria bill to Medicare?
In 2024, Dr. Mosalpuria's most billed Medicare services were injected or infused drug (J1439), injected or infused drug (J9144) and injected or infused drug (J9271).
What drugs does Dr. Kailash Mosalpuria prescribe most?
In 2024 Medicare Part D data, Dr. Mosalpuria's most prescribed drugs by claims were Letrozole, Acyclovir and Jakafi.
Has Dr. Kailash Mosalpuria received payments from drug or device companies?
CMS Open Payments shows $20,386 in general payments to Dr. Mosalpuria from 43 companies from 2016 to 2025. The largest total came from Geron Corporation.
How long has Dr. Kailash Mosalpuria been practicing?
Dr. Mosalpuria graduated from medical school in 2005, 21 years ago.
Does Dr. Kailash Mosalpuria do research?
Dr. Mosalpuria has worked on 1 clinical trial.
Selling to hematology and oncology practices?
See hematologists and oncologists in Nebraska by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card